Efficacy and safety of vitamin D supplementation in asthmatic children who are vitamin D deficient: a randomized controlled trial (ESDAC trial) - ESDAC trial

INDIAN COUNCIL OF MEDICAL RESEARCH0 个研究点目标入组 250 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1)Children 4 to 12 years of age.
•2)Physician diagnosed persistent asthma receiving regular inhaled corticosteroids. All (mild, moderate, and severe) persistent asthma receiving any dose of inhaled steroids will be eligible for study. Both old and new cases of persistent asthma and all types (atopic, non-atopic) of persistent asthma will be included for study.
•(3) Vitamin D levels < 20 ng/ml

•1)Clinically having rickets.
•2)Children with chronic diseases like chronic renal failure, chronic liver disease, or any bone disease.
•3)Mental retardation.
•4)Receiving vitamin D supplementation.
•5)Received a mega dose of vitamin D (3 lac-6 lac units) in last one month.
•6)Any patient that in the opinion of investigators is unlikely to follow up.
•7)Participation in any other clinical trial within 3 months prior to enrolment
•8)Parents not giving consent.

发起方